Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jan 12, 2017Top 100 most innovative companies shift focus from quantity to quality
PHILADELPHIA, January 10, 2017 - Clarivate Analytics, formerly the Intellectual Property & Science business of Thomson Reuters, today announced its highly anticipated list of 2016 Top 100 Global...
-
Jan 11, 2017
Franklin Lakes, NJ (January 11, 2017) - Franklin Lakes, NJ (January 11, 2017) - BD(Becton, Dickinson and Company)(NYSE:BDX) announced today that it will conduct a live webcast of its first fiscal...
-
Jan 9, 2017
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 35th Annual J. P. Morgan Healthcare Conference on Wednesday,...
-
Jan 9, 2017
Franklin Lakes, NJ (January 9, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 35th Annual J. P....
-
Dec 19, 2016
Singapore, 19 December 2016 - SSON Analytics, the global data analytics centre of the Shared Services & Outsourcing Network (SSON), has today announced the launch of a new benchmarking study with...
-
Dec 15, 2016New BD Neopak(TM) 2.25 mL Prefillable Glass Syringe Helps Improve Safety and Convenience for Patients
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Neopak(TM) 2.25 mL prefillable glass syringe, specifically...
-
Dec 9, 2016
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) today issued the following statement to congratulate Dr. John Nkengasong on his appointment as the first director of the newly established...
-
Dec 5, 2016Experience the Difference of Enterprise-wide Medication Management at #ASHP16 Midyear Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate an enhanced technology platform designed with the ability to synchronize BD medication...
-
Dec 1, 2016New Operating System Offers Health Systems Long-Term Medication Management Platform and Enhanced Cybersecurity
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced adoption of Windows 10 Internet of Things (IoT) operating system (OS) for its...
-
Nov 17, 2016
Franklin Lakes, NJ (November 14, 2016) - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will host an institutional investor and analyst meeting on Thursday, November 17,...
-
Nov 17, 2016
Earnings Releases / Presentations About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery,...
-
Nov 10, 2016BD to Showcase Latest Advancements at the 16th Annual Diabetes Technology Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced a new research collaboration supported by JDRF, the leading global organization funding...
-
Nov 8, 2016BD and Lilly Diabetes Collaboration Offers New Delivery Solution for People with Insulin Resistance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company announced today the launch of the BD(TM) U-500 Insulin Syringe, the first insulin syringe developed for...
-
Nov 3, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Oct 31, 2016Expands Reproductive and Sexually Transmitted Infections Portfolio with First Test Using Microbiome-based Algorithm for Bacterial Vaginosis Detection
FRANKLIN LAKES, N.J., Oct. 31, 2016 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) market...
-
Oct 4, 2016Apax Funds to be majority owner of new company, Vyaire Medical
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Apax Partners, today announced the launch of a joint venture - Vyaire Medical - a standalone,...
-
Sep 30, 2016New BD Phoenix(TM) M50 System delivers modularity, reliability, affordability and high-quality susceptibility results needed by clinical microbiology laboratories worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation diagnostic instrument for the rapid identification of...
-
Sep 29, 2016The New BD Vacutainer® Barricor(TM) Tube Offers First Major Advance in Plasma Separation Technology in Decades
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Vacutainer(®)...
-
Sep 22, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its...
-
Sep 21, 2016New BD Veritor(TM) Plus System Enables Fast and Accurate Test Results for Health Care Providers
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of...
-
Sep 16, 2016BD ChloraShield(TM) Dressings are Now Available for a Range of Vascular Access Procedures
BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies(TM), an Avery Dennison (NYSE: AVY) business, today launched a line of transparent vascular dressings with...
-
Sep 13, 2016BD Obtains FDA Clearance for the BD MAX CT/GC/TV Assay on the BD MAX™ System
FRANKLIN LAKES, N.J., Sept. 13, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained U.S. Food and Drug...
-
Sep 12, 2016Latest Release of Industry-Leading Pyxis ES platform Advances Enterprise-wide Medication Management and Patient Safety Across Continuum of Care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced general availability of the latest software release of Pyxis(TM) ES System, delivering...
-
Sep 6, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has submitted a pre-market approval (PMA) application to the U.S. Food and Drug...
-
Sep 1, 2016New Recommendations Based on Findings from Largest-Ever International Survey of more than 13,200 Insulin-Injecting Patients from 42 Countries
The prestigious medical journal, Mayo Clinic Proceedings , today published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the...
-
Aug 18, 2016Announces $20 Million Investment to Support Growth
SANDY, Utah, Aug. 18, 2016 /PRNewswire/ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined by senior public officials today to celebrate...
-
Aug 16, 2016Alaris(TM) System Also Cited as Most Comprehensive Infusion Platform
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Alaris(TM) System infusion platform was cited as having the most customers...
-
Aug 15, 2016
FRANKLIN LAKES, N.J., August 15, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug...
-
Aug 4, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 26, 2016 – The Board of Directors BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on September...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 28, 2016 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that R. Andrew “Andy” Eckert has been...
-
Jul 19, 2016More than 100 Hospitals Have Implemented Interoperability for Alaris(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that more than 100 hospitals and health systems have implemented the company's...
-
Jul 1, 2016
FRANKLIN LAKES, NJ July 1, 2016 – BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2016 earnings conference call on...
-
Jun 16, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a development and global distribution agreement with Check-Points for BD MAX(TM) assays...
-
May 26, 2016First Live Demonstration of the New Cell Sorter at Upcoming CYTO Annual Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, continues to reinforce its commitment to making flow cytometry easier and more affordable with the...
-
May 5, 2016
Click on the links below to view results for 2016 Second Fiscal Quarter: View document online » PDF File of BD 2016 Second Fiscal Quarter Results » About BD BD is one of the largest global...
-
Apr 26, 2016New BD U-40 Pet Syringes Available at Veterinary Offices
FRANKLIN LAKES, N.J., April 26, 2016 – BD (Becton, Dickinson and Company), a leading medical technology company, announced today that it has launched BD Pet Syringes – veterinary insulin...
-
Apr 22, 2016Genesis(TM) Low Temperature Rigid Sterilization Container System Validated for Modern Low-Temp Sterilization Practices
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new line of surgical instrument sterilization containers that are validated for the...
-
Apr 21, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®,...
-
Mar 30, 2016
FRANKLIN LAKES, N.J., Mar. 30, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Mar 15, 2016Marks sixth year in top spot for infection control and monitoring category
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that BD MedMined(®) Surveillance Advisor has been named a 2015/2016 Category Leader for...
-
Mar 8, 2016Apax Funds will be majority owner of new company
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a definitive agreement to sell 50.1 percent of its Respiratory Solutions business to...
-
Mar 7, 2016Adds BD Totalys(TM) MultiProcessor and BD Totalys(TM) SlidePrep for Gynecological Specimen Preparation to Cytology Instrumentation Portfolio
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys(TM)...
-
Mar 6, 2016BD Vacutainer® Barricor™ Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time
FRANKLIN LAKES, N.J., March 1, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in Europe for a...
-
Mar 1, 2016
BD Vacutainer® Barricor(TM) Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time FRANKLIN LAKES, N.J., March 1, 2016 /PRNewswire/ -- BD...
-
Mar 1, 2016BD Exhibits Next Generation Wireless Diagnostic Test System at #HIMSS16
LAS VEGAS, March 1, 2016 –BD (Becton, Dickinson and Company), a leading global medical technology company, is utilizing AT&T* Internet of Things (IoT) services to connect wireless health...
-
Feb 24, 2016
FRANKLIN LAKES, N.J., Feb. 24, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Alaris™ System has been named 2015...
-
Feb 22, 2016
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: 2016 RBC...
-
Feb 17, 2016Novel PentaPoint(TM) Comfort and RightGauge(TM) Needle Technologies Help Improve Comfort, Access to Difficult Veins
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE marking...
-
Feb 12, 2016BD CLiC(TM) System is the first, high-throughput, fully integrated, automated bench-top library preparation workflow
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD CLiC(TM) System during the 2016 Advances in Genome Biology and...
-
Feb 8, 2016Innovation Results from Collaboration with the National Institutes of Health
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony(TM) system, a novel cell analyzer enabling the...
-
Feb 5, 2016Revenue increased 16 percent to $1.07 billion
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its fiscal second quarter, growing revenue in every business line and major...
-
Feb 5, 2016Tests from DiabetOmics to be Integrated into BD Veritor™ Point-of-Care Diagnostic Platform
FRANKLIN LAKES, N.J., Feb. 5, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has entered into a licensing and distribution...
-
Feb 3, 2016
Click on the links below to view results for 2016 First Fiscal Quarter: View document online » PDF File of BD 2016 First Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jan 25, 2016
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on March 31, 2016 to holders of record on March 10,...
-
Jan 21, 2016BD leverages Singularity University’s network of solution-shaping experts, faculty, development partners and a highly-engaged global community
MOUNTAIN VIEW, CA and FRANKLIN LAKES, NJ January 21, 2016 – Singularity University (SU), a benefit corporation focused on empowering leaders to leverage exponentially growing technologies to...
-
Jan 15, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 26,...
-
Jan 8, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Fresenius Kabi USA has acquired the BD Rx business, which includes a...
-
Jan 8, 2016
FRANKLIN LAKES, N.J. and LAKE ZURICH, Ill.,January 8, 2016 – Becton, Dickinson and Company (BD) (NYSE: BDX) and Fresenius Kabi USA announced today that Fresenius Kabi has acquired the BD Rx...
-
Jan 7, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2016 earnings conference call on Wednesday, February 3, 2016, at 8:00...
-
Jan 4, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 34th Annual J. P. Morgan Healthcare Conference on...
-
Dec 12, 2015State-of-the-Art Research System Optimized for Use with BD Horizon Brilliant(TM) Dyes Is Now Available Worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSCelesta(TM) flow cytometer during the 2015 American Society...
-
Dec 10, 2015
FRANKLIN LAKES, N.J., Dec. 10, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced the U.S. Food and Drug Administration (FDA) has cleared two 510(k)s for its spine...
-
Dec 7, 2015Combined Technologies from BD, CareFusion Create End-to-End IV Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve...
-
Dec 2, 2015Visit the "BD Leadership Theater" to hear how health systems improve and advance quality and safety across the continuum of care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and CareFusion, a BD company, will present its combined, strengthened solutions together as one company,...
-
Nov 23, 2015
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.66 cents per common share, an increase of 10.0 percent from the previous quarter....
-
Nov 12, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Stifel 2015 Healthcare Conference Tuesday, November 17,...
-
Nov 7, 2015American Association for Respiratory Care (AARC) Presents Award at Annual Congress
TAMPA, Fla., Nov. 7, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory...
-
Nov 6, 2015
TAMPA, Fla., Nov. 6, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or...
-
Nov 5, 2015AirLife to Offer Nasal High Flow Interfaces from ResMed
SAN DIEGO, CA, Nov. 5, 2015/PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute...
-
Nov 4, 2015- Announces full fiscal year adjusted revenues of $10.302 billion, an increase of 22.0 percent, or 29.5 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 5.3 percent for the full year. As reported, full-year revenues increased 21.7 percent to $10.282 billion.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended...
-
Oct 26, 2015Companies to Establish Interoperability between Hemodynamic Monitoring Systems and Infusion Devices
SAN DIEGO and IRVINE, Calif., October 23, 2015 – Edwards Lifesciences and CareFusion, a BD company, today announced a collaboration agreement to enable interoperability between patient...
-
Oct 26, 2015Companies to Establish Interoperability between Hemodynamic Monitoring Systems and Infusion Devices
SAN DIEGO and IRVINE, Calif., October 23, 2015 – Edwards Lifesciences and CareFusion, a BD company, today announced a collaboration agreement to enable interoperability between patient...
-
Oct 6, 2015Study to be Presented at the American Society of Human Genetics 2015 Annual Meeting Demonstrates Applications for High-Resolution Gene Expression Studies
BALTIMORE and SAN JOSE, Calif., Oct. 6, 2015 – BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today launched its first...
-
Oct 5, 2015
FRANKLIN LAKES, N.J., Oct. 05, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its participation in National Health...
-
Oct 4, 2015
FRANKLIN LAKES, N.J., Oct. 1, 2015 – BD(Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2015...
-
Oct 2, 2015
BALTIMORE, MD., Oct. 02, 2015 – BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Johns Hopkins University (JHU)...
-
Oct 1, 2015
FRANKLIN LAKES, N.J., Oct. 1, 2015 – BD(Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2015...
-
Sep 29, 2015FDA Updates March 2015 Safety Alert on CSTD Compatibility for Treanda® Injection
September 29, 2015 - Today BD (Becton, Dickinson and Company), notified customers that the U.S. Food and Drug Administration (FDA) has updated its March 2015 Safety Alert based on Teva...
-
Sep 24, 2015
SPARKS, MD., Sept. 24, 2015 – BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the availability of the U.S. Food...
-
Sep 16, 2015Vyntus® WALK Wirelessly Assesses Functional Exercise Capacity
SAN DIEGO, CA, Sept. 16, 2015 – CareFusion, a BD company (NYSE: BDX), announces the availability of a new respiratory diagnostics tool that is a complete mobile solution for assessing functional...
-
Sep 15, 2015
CHICAGO, IL, Sept. 15, 2015 – The Product Development and Management Association (PDMA), the premier global advocate for product development and management professionals, announced today that it...
-
Sep 14, 2015
SEOUL, KOREA and BALTIMORE, MD, Sept. 14, 2015 – Seegene Inc. (096530.KQ) and BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) today announced that they have entered...
-
Sep 3, 2015TechValidate Survey Supports Benefits of Pyxis ES Platform for Health System Pharmacy Operations
SAN DIEGO, CA, Sept. 3, 2015 – PRNewswire/ -- CareFusion, a BD company (NYSE: BDX), announces that its enterprise-level Pyxis® ES platform, developed to help hospitals and health systems better...
-
Aug 27, 2015Commitments include cash and product donations through AmeriCares, Direct Relief, Heart to Heart International, Project HOPE, Save the Children and UNICEF
FRANKLIN LAKES, N.J., Aug. 27, 2015 – BD (Becton, Dickinson and Company), a leading global medical technology company, has committed $700,000 in aid to assist those affected by the April 2015...
-
Aug 25, 2015
FRANKLIN LAKES, N.J., Aug. 25, 2015 – BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed...
-
Aug 6, 2015- Announces adjusted revenues of $3.133 billion, an increase of 45.2 percent, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues of $3.120 billion increased 44.6 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June...
-
Jul 28, 2015
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 60 cents per common share, payable on September 30, 2015 to holders of record on...
-
Jul 13, 20152014 Sustainability Report outlines new integrated strategy and goals to create more sustainable healthcare solutions
FRANKLIN LAKES, N.J., July 13, 2015 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today an updated sustainability strategy and goals for...
-
Jun 27, 2015Results from independent analysis of survey of more than 600 hospitals presented today at the 42nd Annual APIC Conference
FRANKLIN LAKES, N.J. June 27, 2015 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that results from a new...
-
Jun 15, 2015BD expands its Massachusetts footprint with “Center of Excellence” to develop next generation technology for diabetes treatment
ANDOVER, MA, July 15, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, officially opened its Advanced Diabetes Care facility in Andover, Mass.,...
-
Jun 10, 2015WellSpan York Becomes First Hospital to Simultaneously Implement New Pumps and Interoperability to EHR
SAN DIEGO and YORK, Pa., June 10, 2015 /PRNewswire/ – WellSpan Health and CareFusion, a BD company (NYSE:BDX), today announced the successful implementation of the Alaris® System across all...
-
Jun 9, 2015CareFusion Has Most Organizations Live and Leads in Breadth of Functionality
CareFusion, a BD company (NYSE:BDX), today announced its Alaris® System intelligent infusion platform has been rated as the smart pump industry leader for interoperability with electronic medical...
-
Jun 8, 2015New Innovation Demonstrates Reductions in Flow Interruptions, Including Silent Occlusions
BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a collaboration to introduce a new...
-
Jun 6, 2015
Studies Presented at the American Diabetes Association's 75(th) Scientific Sessions Demonstrate Potential Benefits of Proprietary Side-Ported Catheter BOSTON, June 6, 2015 /PRNewswire/ -- BD...
-
Jun 2, 2015Commits to Multiple Actions to Help Combat Antimicrobial Resistance
FRANKLIN LAKES, N.J.,June 02, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its participation in the White House Forum on...
-
May 27, 2015
CareFusion, a BD company (NYSE:BDX), provided an update on a global voluntary recall that was initiated on April 21, 2015 to address an issue with certain units of AVEA® ventilators. The recall...
-
May 13, 2015Unique Side-Ported Catheter Designed to Offer Consistent Insulin Delivery and Fewer Flow Interruptions including Silent Occlusions
FRANKLIN LAKES, N.J., May 13, 2015 – BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received 510(k)...
-
May 5, 2015BD Medication & Procedural Solutions and Pharmaceutical Systems sites in Columbus push to close skills gap needed by local industry
COLUMBUS, NE, May 5, 2015 – BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, has awarded $12,000 in scholarships to three local high...
-
May 4, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Bank of America Merrill Lynch 2015 Healthcare Conference on...